by Cameron.Begley@spiegare.com.au | Mar 27, 2025 | Bioeconomy, Commercialisation, TechTransfer, Venture Capital
In this episode, I had the great pleasure of catching up with Roger Wyse, Founder and Managing Partner at Spruce Capital Partners. I have had the pleasure of collaborating with Roger over the past decade (or more) and have always found his insights of great value and...
by Cameron.Begley@spiegare.com.au | Sep 28, 2023 | Chemicals, Fumigants, Innovation, TechTransfer
In this episode, my guest is Shona Faber, Non-Executive Director of ARB Corporation, previously Managing Director CRC Industries, and General Manager of Specialty Gases & Chemicals at BOC. We talk about her experiences in bringing EDN, a novel fumigant chemical,...
by Cameron.Begley@spiegare.com.au | Jun 29, 2023 | Alt-Protein, Commercialisation, Innovation, TechTransfer
About this episode In this episode, we were pleased to have a wide-ranging discussion with Professor Paul Wood AO. We talk about his start at CSIRO and the pathway to his breakthrough in TB tests for cattle in the Northern Territory, and how it opened a pathway into...
by Cameron.Begley@spiegare.com.au | Jan 26, 2023 | Commercialisation, Innovation, Start-up, TechTransfer
About this episode In this episode, Dr Katherine Woodthorpe AO joins us to explore the challenges of moving from start-up to scale-up. From addressing foundational tech transfer challenges such as articulating product benefits and identifying market needs, we discuss...
by Cameron.Begley@spiegare.com.au | Sep 28, 2022 | Commercialisation, Innovation, TechTransfer
About this episode We are delighted to share episode #13 where Cameron, our podcast host, reflects on the range of themes we have had through our first 12 podcasts and in which he specifically explores the importance of time and timing in tech transfer. Transcript CB:...
